curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

SII Levels Following PENG Block in Hip Arthroplasty

by palligoelme@gmail.com | Mar 4, 2026 | Clinical Trials

​ Conditions: Hip Osteoarthritis Interventions: Drug: sodium Chloride; Drug: Ropivacaine 0.2% Injectable Solution Sponsors: Poznan University of Medical Sciences Not yet recruiting Conditions: Hip Osteoarthritis Interventions: Drug: sodium Chloride; Drug: Ropivacaine...

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Resectable Hepatocellular Carcinoma Interventions: Drug: ateganosine; Drug: Cadonilimab Sponsors: University of Texas Southwestern Medical Center; Maia Biotechnology; National Cancer Institute (NCI) Not yet recruiting Conditions: Resectable...

Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Laparoscopic Cholecystectomy; Postoperative Pain Management; Regional Anesthesia Interventions: Procedure: External Oblique Plane Block (EOPB); Procedure: Serratus Intercostal Plane Block (SIPB) Sponsors: Samsun University Recruiting Conditions:...

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Breast Cancer; Central Nervous System Metastases Interventions: Diagnostic Test: Primary Tumor mRNA Expression Profiling (NGS); Diagnostic Test: Serum Chemokine Quantification (ELISA) Sponsors: Institute of Oncology Ljubljana Active, not...

A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Advanced Esophageal Squamous Cell Carcinoma Interventions: Drug: anlotinib combined with benmelstobart; Drug: Toripalimab Combined with Chemotherapy Sponsors: The First Affiliated Hospital of Zhengzhou University Not yet recruiting Conditions: Advanced...

Targeted Nerve Injection to the Knee (Nerve to Vastus Medialis): Comparing Two Adductor Canal Block Approaches

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Anesthesia, Local Interventions: Procedure: Traditional adductor canal block; Procedure: NVM (nerve to vastus medialis) targeted adductor canal block; Drug: Chloroprocaine Injection Sponsors: Duke University Not yet recruiting Conditions: Anesthesia,...
« Older Entries
Next Entries »

Recent Posts

  • Factors Affecting Immediate Anterior Implants. Reterosepective Clinical Study
  • A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
  • Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD
  • Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction
  • Periodontal Gel in NSPT

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®